Search research articles
Contact Us
Filters
Showing results (21-30 of 245) with videos related to
Page
of 25
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 18, 2018
Does Rheumatoid Arthritis Cause an Obesity Paradox? Comment on the Article by Sparks et al
Joshua F Baker, Gail Kerr, Ted R Mikuls
Angiology
|
September 19, 2007
Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial
Joshua F Baker, H Ralph Schumacher, Eswar Krishnan
Annals of the Rheumatic Diseases
|
March 12, 2017
Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis?
Joshua F Baker, Mikkel Østergaard, Philip G Conaghan
Best Practice & Research. Clinical Rheumatology
|
June 23, 2022
Osteoporosis and fractures in rheumatoid arthritis - risk factors
Katherine D Wysham, Joshua F Baker, Radhika Narla
Rheumatology (Oxford, England)
|
February 8, 2014
Management of rheumatoid arthritis
Joshua F Baker, Sally Pullman-Mooar, Said Ibrahim
Medicine
|
August 19, 2016
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
Michael D George, Neilia-Kay McGill, Joshua F Baker
Annals of the Rheumatic Diseases
|
February 23, 2021
Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti <i>et al</i>
Joshua F Baker, Bryant R England, Ted R Mikuls
Clinical and Experimental Rheumatology
|
February 24, 2017
Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF
Prateek C Gandiga, Michael D George, Joshua F Baker
Current Opinion in Rheumatology
|
March 2, 2021
Osteoporosis and fractures in rheumatoid arthritis
Katherine D Wysham, Joshua F Baker, Dolores M Shoback
Best Practice & Research. Clinical Rheumatology
|
December 25, 2015
Monitoring in established RA: Role of imaging and soluble biomarkers
Joshua F Baker, York Kiat Tan, Philip G Conaghan
Page
of 25
Search research articles
Search
Showing results (21-30 of 245) with videos related to
Sort By:
Page
of 25
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 18, 2018
Does Rheumatoid Arthritis Cause an Obesity Paradox? Comment on the Article by Sparks et al
Joshua F Baker, Gail Kerr, Ted R Mikuls
Angiology
|
September 19, 2007
Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial
Joshua F Baker, H Ralph Schumacher, Eswar Krishnan
Annals of the Rheumatic Diseases
|
March 12, 2017
Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis?
Joshua F Baker, Mikkel Østergaard, Philip G Conaghan
Best Practice & Research. Clinical Rheumatology
|
June 23, 2022
Osteoporosis and fractures in rheumatoid arthritis - risk factors
Katherine D Wysham, Joshua F Baker, Radhika Narla
Rheumatology (Oxford, England)
|
February 8, 2014
Management of rheumatoid arthritis
Joshua F Baker, Sally Pullman-Mooar, Said Ibrahim
Medicine
|
August 19, 2016
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
Michael D George, Neilia-Kay McGill, Joshua F Baker
Annals of the Rheumatic Diseases
|
February 23, 2021
Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti <i>et al</i>
Joshua F Baker, Bryant R England, Ted R Mikuls
Clinical and Experimental Rheumatology
|
February 24, 2017
Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF
Prateek C Gandiga, Michael D George, Joshua F Baker
Current Opinion in Rheumatology
|
March 2, 2021
Osteoporosis and fractures in rheumatoid arthritis
Katherine D Wysham, Joshua F Baker, Dolores M Shoback
Best Practice & Research. Clinical Rheumatology
|
December 25, 2015
Monitoring in established RA: Role of imaging and soluble biomarkers
Joshua F Baker, York Kiat Tan, Philip G Conaghan
Page
of 25